Clinical Report: Linking the Systemic Immune-Inflammation Index to Post-Stroke Depression

Overview

This meta-analysis investigates the association between the systemic immune-inflammation index (SII) and post-stroke depression (PSD), finding that elevated SII levels significantly increase the risk of PSD. The results suggest that SII may serve as a valuable biomarker for early identification of patients at risk for developing PSD.

Background

Post-stroke depression is a prevalent complication affecting 20-35% of stroke survivors, leading to impaired recovery and increased mortality. Despite established clinical risk factors, reliable biomarkers for early detection of PSD are lacking. The systemic immune-inflammation index (SII) has emerged as a potential tool to assess inflammation-related risks in stroke patients.

Data Highlights

Key Findings

• High SII at admission is associated with a twofold increased risk of PSD (OR = 2.14).
• Findings are consistent across various study designs and patient demographics.
• Sensitivity analyses confirmed the stability of the association between SII and PSD.
• Elevated SII reflects systemic immune dysregulation linked to depressive symptoms.
• SII may facilitate early identification of patients at risk for PSD.

Clinical Implications

Healthcare professionals should consider the systemic immune-inflammation index as a potential biomarker for assessing the risk of post-stroke depression. Early identification of patients with elevated SII may enable targeted interventions to improve recovery outcomes.

Conclusion

The systemic immune-inflammation index is a promising tool for identifying stroke patients at risk for post-stroke depression, potentially guiding early therapeutic strategies.

Related Resources & Content

1. Frontiers in Neurology, 2026 -- Systemic immune-inflammation index predicts post-thrombectomy outcomes and reveals a mediating role in the association between neurocardiac stress and prognosis: a multicenter study
2. Frontiers in Psychiatry, 2026 -- Effectiveness of mindfulness-based stress reduction for depression in post-stroke patients: a systematic review and meta-analysis
3. Frontiers in Psychiatry, 2026 -- Poststroke anxiety and depression: epidemiology, mechanisms, and management strategies
4. Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery and Community Participation Following Stroke. Part One: Stroke Rehabilitation Planning for Optimal Care Delivery, 7th Edition Update 2025 - PMC
5. Frontiers | The association between systemic immune-inflammation index and post-stroke depression: a meta-analysis
6. Frontiers in Immunology — Beyond the usual suspects: rethinking post-stroke immunosuppression
7. Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery and Community Participation Following Stroke. Part One: Stroke Rehabilitation Planning for Optimal Care Delivery, 7th Edition Update 2025 - PMC
8. Frontiers | The association between systemic immune-inflammation index and post-stroke depression: a meta-analysis